Click here to read the Cover Story, “Specialists address challenges of microbial keratitis management.”
There are two lines of research we are pursuing in our lab currently.
The first is phage therapy, a strategy that is approved in Europe and used as an alternative to antibiotics in other fields of medicine, mainly for skin infections. Phages are viruses that infect the bacteria and through the production of specific enzymes — the endolysins — kill them from within. In 2014, we showed in our lab the efficacy of phage endolysin therapy (Read more...)